Cite
HARVARD Citation
Roblin, X. et al. (2017). Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open‐label, prospective and randomised clinical trial. Alimentary pharmacology & therapeutics. 46 (2), pp. 142-149. [Online].